HCW Biologics (HCWB) Price & Analysis

Compare

130 Followers

HCWB Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.55 - $100.80

Previous CloseN/A

Volume102.01K

Average Volume (3M)226.27K

Market Cap

$10.28M

Enterprise Value$15.65M

Total Cash (Recent Filing)$1.11M

Total Debt (Recent Filing)$6.23M

Price to Earnings (P/E)―

Beta0.76

Next Earnings

Aug 08, 2025

EPS Estimate

1.8

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.00

Shares Outstanding2,413,499

10 Day Avg. Volume200,611

30 Day Avg. Volume226,266

Financial Highlights & Ratios

PEG Ratio-0.41

Price to Book (P/B)-22.65

Price to Sales (P/S)0.00

P/FCF Ratio-0.73

Enterprise Value/Market Cap1.52

Enterprise Value/Revenue1.37

Enterprise Value/Gross Profit45.27

Enterprise Value/Ebitda-0.13

Forecast

1Y Price Target

$35.00

Price Target Upside721.60% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

HCW Biologics News

PremiumCompany Announcements

HCW Biologics Secures $7M License Fee Agreement

11d ago

HCWB

PremiumCompany Announcements

HCW Biologics Advances Alopecia Areata Treatment with New Phase 1 Study

18d ago

HCWB

PremiumCompany Announcements

HCW Biologics Completes Warrant Exercise with Armistice

28d ago

HCWB

PremiumCompany Announcements

HCW Biologics Regains Nasdaq Compliance as of June 2025

1M ago

HCWB

PremiumThe Fly

HCW Biologics regains compliance with Nasdaq Capital Market requirements

1M ago

HCWB

PremiumCompany Announcements

HCW Biologics Board Member Resignation and Director Elections

1M ago

HCWB

PremiumCompany Announcements

HCW Biologics Sees Strong Investor Interest in June

2M ago

HCWB

PremiumCompany Announcements

HCW Biologics Meets Nasdaq Listing Requirements in May 2025

2M ago

HCWB

See All HCWB News

See All News >

Bulls Say, Bears Say

Bulls Say

Clinical TrialsHCW Biologics announced the clearance of HCW9302 to enter a Phase 1 clinical trial in patients with moderate to severe alopecia areata.

Financial PerformanceHCW Biologics has made considerable progress in shoring up its balance sheet and advancing its pipeline following a challenging legal issue and arbitration.

Market InterestThe key value driver here is that it places the company in the highly active immune cell engager space which has drawn significant attention from investors and Pharma.

Strategic PartnershipsThe agreement with WY Biotech provides important validation for HCW Biologics' new discovery platform and favorable economics.

Bears Say

Financial OutlookDilution has led to a lower 12-month price target, reduced from $120 to $35 (split-adjusted).

Legal ExpensesDespite recent capital influx, HCW Biologics has remaining legal expenses of $14.4M and may require further capital.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

24.13% Insiders

5.03% Mutual Funds

5.45% Other Institutional Investors

75.62% Public Companies and

Individual Investors

Detailed Ownership Overview >

HCWB FAQ

What was Hcw Biologics, Inc.’s price range in the past 12 months?

Hcw Biologics, Inc. lowest stock price was $3.55 and its highest was $100.80 in the past 12 months.

What is Hcw Biologics, Inc.’s market cap?

Hcw Biologics, Inc.’s market cap is $10.28M.

When is Hcw Biologics, Inc.’s upcoming earnings report date?

Hcw Biologics, Inc.’s upcoming earnings report date is Aug 08, 2025 which is in 10 days.

How were Hcw Biologics, Inc.’s earnings last quarter?

Currently, no data Available

Is Hcw Biologics, Inc. overvalued?

According to Wall Street analysts Hcw Biologics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hcw Biologics, Inc. pay dividends?

Hcw Biologics, Inc. does not currently pay dividends.

What is Hcw Biologics, Inc.’s EPS estimate?

Hcw Biologics, Inc.’s EPS estimate is 1.8.

How many shares outstanding does Hcw Biologics, Inc. have?

Hcw Biologics, Inc. has 2,413,499 shares outstanding.

What happened to Hcw Biologics, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Hcw Biologics, Inc.?

Currently, no hedge funds are holding shares in HCWB

HCW Biologics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-9999.00%

Trailing 12-Months

Asset Growth

-13.61%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Hcw Biologics, Inc.

HCW Biologics (HCWB) is a biotechnology company focused on the discovery and development of novel immunotherapies to treat age-related diseases and cancer. The company is engaged in research and development of biologic products aimed at improving immune system function through their proprietary platform, which leverages advanced protein engineering techniques to create multi-functional therapeutic molecules.

HCWB Stock 12 Month Forecast

Average Price Target

$35.00

▲(721.60%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","83":"$83","22.25":"$22.3","42.5":"$42.5","62.75":"$62.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,22.25,42.5,62.75,83],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"May<br/>2024","9":"Feb<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,6.153846153846153,8.557692307692307,10.961538461538462,13.365384615384615,15.769230769230768,18.173076923076923,20.576923076923077,22.98076923076923,25.384615384615383,27.788461538461537,30.19230769230769,32.59615384615385,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,6.153846153846153,8.557692307692307,10.961538461538462,13.365384615384615,15.769230769230768,18.173076923076923,20.576923076923077,22.98076923076923,25.384615384615383,27.788461538461537,30.19230769230769,32.59615384615385,{"y":35,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,6.153846153846153,8.557692307692307,10.961538461538462,13.365384615384615,15.769230769230768,18.173076923076923,20.576923076923077,22.98076923076923,25.384615384615383,27.788461538461537,30.19230769230769,32.59615384615385,{"y":35,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":72.4,"date":1677628800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.04,"date":1680307200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.24,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.6,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.07,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.2,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.73,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.21,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >